With the relaxation of mask-wearing mandates, there’s even more need to know how much over-the-counter tests help.
Academic rigor, journalistic flair
Articles on EUA
Displaying all articles
Moderna will ask the FDA to allow emergency use for its vaccine in children as young as 6 months, a step many parents have been anticipating.
The COVID-19 vaccine rollout has fallen far short of President Trump’s promises. President Biden says he can fix that. Can he?
Millions of Americans say they won’t get the vaccine. Will money change their minds? And is luring them with cash the right approach?
The vaccines that will first be used to prevent the spread of COVID-19 will have gone through a special approval process with the FDA. but just what is this expedited process?
The rushed emergency approval for a treatment that might help COVID-19 patients has raised questions: Is the FDA abandoning its own guidelines?
To battle the coronavirus, strong regulatory protection from the FDA is essential.
Top contributors
-
Professor of Law, Boston University
-
Professor of Law, Villanova School of Law
-
Professor of Medicine, Economics and Health Promotions Science, University of Arizona
-
Assistant Professor of Medical Ethics, University of Pennsylvania
-
Professor of Law, University of Maryland
-
Professor of Law, Public Health Sciences, and Public Policy, University of Virginia
-
Professor of Medicine, Johns Hopkins University
-
Professor of Law, Saint Louis University
-
Associate Professor of Pediatrics, University of Virginia
-
Assistant Professor of Molecular Medicine, UMass Chan Medical School
-
Research Assistant Professor, Division of Medical Ethics, New York University
-
Assistant Professor of Medicine, UMass Chan Medical School
-
Professor of Law, Georgia State University
